产品名称 | LY 2801653 - Merestinib |
产品货号 | Axon 2553 CAS [1206799-15-6] MF C30H22F2N6O3MW 552.53 Purity: 99% Soluble in DMSO Description Orally bioavailable multi-kinase inhibitor with potent activity against c-MET (IC50 values 35 - 53 nM for cell-based activity), and several other receptor tyrosine oncokinases including MST1R, FLT3, AXL, MERTK, TEK, ROS1, DDR1, DDR2 and against the serine/threonine kinases MKNK1 and MKNK2 (IC50 values 11, 7, 2, 10, 63, 23, 0.1, 7, 7, and 7 nM, respectively). In classic and orthotopic mouse xenograft models of lung cancer, LY2801653 decreased tumor growth, dramatically inhibiting mitotic events and angiogenesis. KEYWORDS: LY 2801653 | supplier | Multi-kinase (c-MET) inhibitor | Merestinib | LY2801653 | CAS [1206799-15-6] | HGF | c-MET | MST1R | Axl | FLT3 | MERTK | TEK | ROS1 | DDR1 | DDR2 | RTKInhibitor | MKNK1 | MKNK2 | oncoproteins |
产品价格 | 现货询价,电话:010-67529703 |
产品规格 | |
产品品牌 | axonmedchem |
产品概述 | |
产品详情 |
LY 2801653 - MerestinibAxon 2553 CAS [1206799-15-6] MF C30H22F2N6O3
DescriptionOrally bioavailable multi-kinase inhibitor with potent activity against c-MET (IC50 values 35 - 53 nM for cell-based activity), and several other receptor tyrosine oncokinases including MST1R, FLT3, AXL, MERTK, TEK, ROS1, DDR1, DDR2 and against the serine/threonine kinases MKNK1 and MKNK2 (IC50 values 11, 7, 2, 10, 63, 23, 0.1, 7, 7, and 7 nM, respectively). In classic and orthotopic mouse xenograft models of lung cancer, LY2801653 decreased tumor growth, dramatically inhibiting mitotic events and angiogenesis. KEYWORDS: LY 2801653 | supplier | Multi-kinase (c-MET) inhibitor | Merestinib | LY2801653 | CAS [1206799-15-6] | HGF | c-MET | MST1R | Axl | FLT3 | MERTK | TEK | ROS1 | DDR1 | DDR2 | RTKInhibitor | MKNK1 | MKNK2 | oncoproteins
Orally bioavailable multi-kinase inhibitor with potent activity against c-MET
Chemical nameN-(3-fluoro-4-(1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yloxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide Parent CAS No.[1206799-15-6] |
产品资料 |